Why Shares of Allakos Are Up Wednesday. Shares of clinical-stage biotech company Allakos (NASDAQ: ALLK) were up more than 15% as of 11:40 a.m. on Wednesday.

  finance.yahoo.com

Track Allakos Inc (ALLK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...

  stocktwits.com

Institutional Ownership and Shareholders. Allakos Inc. (US:ALLK) has 264 institutional owners and shareholders that have filed 13D/G or 13F forms with the ...

  fintel.io

View live Allakos Inc. chart to track its stock's price action. Find market predictions, ALLK financials and market news.

  www.tradingview.com

About Institutional Holdings. Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, ...

  www.nasdaq.com

Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases.

  www.allakos.com

Key Data · Open $2.7400 · Day Range 2.6800 - 2.7850 · 52 Week Range 1.4750 - 8.7300 · Market Cap $238.81M · Shares Outstanding 87.48M · Public Float 66.9M ...

  www.marketwatch.com

UH60 Blackhawk Light String Kit ... Description: The UH60 customized Light String Kit (ALLK-60) includes the light strings listed, storage cases (ALSB-5441 & ALBB ...

  www.fsirivet.com

SAN CARLOS, Calif. , Nov. 13, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the ...

  investor.allakos.com

Allakos Inc. Common Stock (ALLK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

  www.nasdaq.com

Page generated - 0.7562141418 (9c3ce06007af88bfbafc8d2ddb1a3752)